Comment on

• Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.

  Stiff PJ, Emmanouilides C, Bensinger WI, Gentile T, Blazar B, Shea TC, Lu J, Isitt J, Cesano A, Spielberger R. Stiff PJ, et al. J Clin Oncol. 2006 Nov 20;24(33):5186-93. doi: 10.1200/JCO.2005.02.8340. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391299 Clinical Trial.
• Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

  Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S. Rosen LS, et al. J Clin Oncol. 2006 Nov 20;24(33):5194-200. doi: 10.1200/JCO.2005.04.1152. Epub 2006 Oct 30. J Clin Oncol. 2006. PMID: 17075109 Clinical Trial.